Skip to main content

News

PrescriberPoint Joins athenahealth Marketplace for AI Prior Authorization

Boston – September 28, 2026 -- PrescriberPoint has joined athenahealth's Partner Community as a Solution Partner, putting its AI-powered prior authorization tool directly into the e-prescribing workflow of more than 170,000 clinicians on the athenaOne network.

Integration lets providers submit prior authorizations without leaving their e-prescribing workflow

The new listing in the athenahealth Marketplace allows providers to initiate and complete prior authorizations using clinical and patient details pulled automatically into the submission. Denied claims can be advanced with appeals and supporting documentation prepared automatically rather than restarted from scratch.

Century Casinos Sells Two Alberta Racinos to Highfield for $16.4M

Image
Century Casinos Sells Two Alberta Racinos to Highfield for $16.4M

Colorado Springs – September 28, 2026 -- Century Casinos, Inc. (Nasdaq: CNTY) has agreed to sell the racing and gaming operations of Century Mile Racetrack and Casino in Edmonton and Century Downs Racetrack and Casino in Calgary to Highfield Investment Group for approximately $16.4 million, a 6.1x multiple of FY 2025 EBITDA.

Deal values Alberta racinos at CAD 23.2 million based on current exchange rates

The purchase price translates to CAD 23.2 million using the September 27, 2026 exchange rate of 0.7074 CAD/USD. Century Casinos owns 100% of Century Mile and a 75% stake in Century Downs, with noncontrolling partners holding the remaining 25% of the latter property.

The9's AI-Built Game Hits No. 1 in Hong Kong, Cuts Dev Time to 8 Months

Shanghai – September 28, 2026 -- The9 Limited (Nasdaq: NCTY) said its mobile simulation title "The Greed of Man《大時代》" reached No. 1 in the Simulation Games category on both the Hong Kong Apple App Store and Google Play following its September 24, 2026 launch.

Game built in eight months versus industry-standard two to three years

The title was produced on the9bit, The9's proprietary AI game production platform that orchestrates multiple AI models across development rather than relying on a single foundation model. The platform converts a natural-language or image-based idea into a structured production blueprint, then coordinates content generation, debugging, asset creation and integration across the pipeline. An AI-native editing environment allows creators to refine gameplay elements, parameters and visuals through further natural-language instructions.

58% of Enterprises Delay Strategic Plans Over Network Provider Trust Gaps

Image
58% of Enterprises Delay Strategic Plans Over Network Provider Trust Gaps

Stockholm – – September 28, 2026 -- More than half of senior enterprise leaders, 58%, have delayed, scaled back or added safeguards to strategic initiatives over the past two years due to concerns about their network provider, according to a new report from Arelion.

The Stockholm-based connectivity firm commissioned research firm Savanta to survey 518 senior enterprise network decision-makers across the US, UK, Germany and France, all from organizations with more than 2,000 employees. The findings appear in Arelion's report, 'The trust illusion: Why AI and digital transformation need more than a reliable network.'

Aglocell Software Unlocks 1 Terabyte of Daily Capacity for Tier-1 US Carrier

Warrenville, Ill. – September 28, 2026 -- Aglocell, Inc. has delivered a Tier-1 U.S. wireless carrier one terabyte of additional daily network capacity through software alone, avoiding an estimated $2.6 million in hardware costs across a single metro deployment.

SpectraMax software lifted peak-hour capacity by 4.1% across 60-plus cell sites

In a live trial spanning more than 60 sites in a major U.S. metropolitan area, Aglocell's SpectraMax platform increased network-wide capacity by 4.1% during peak busy hour, equal to roughly one terabyte of additional data throughput. The company says the gain matches one-third of a full new spectrum layer, a physical buildout that typically costs carriers $43,000 per cell site, or nearly $2.6 million across the tested sites.

AbbVie Wins FDA Approval for First D1/D5 Parkinson's Drug JUVMO

North Chicago, Ill. – – September 28, 2026 -- AbbVie (NYSE: ABBV) has secured U.S. FDA approval for JUVMO (tavapadon), the first and only selective D1/D5 receptor agonist for adults with Parkinson's disease, with commercial availability set for October 2026.

JUVMO targets dopamine pathways differently than existing D2/D3 agonists

Roopal Thakkar, AbbVie's chief scientific officer, called the approval the first dopaminergic breakthrough for Parkinson's disease in decades. The once-daily oral tablet can be taken with or without levodopa, positioning it across the full disease continuum rather than a single treatment stage.

Duck Creek Launches Agentic FNOL to Automate Claims Intake

Image
Duck Creek Launches Agentic FNOL to Automate Claims Intake

Boston – September 28, 2026 -- Duck Creek has made Agentic First Notice of Loss (FNOL) available to early access customers, an AI-driven tool designed to automate claims intake across digital, voice-to-text, and mobile channels.

Agentic AI agents verify coverage and flag anomalies before an adjuster opens the file

Built on the Duck Creek Agentic AI Platform, the solution uses orchestrated AI agents to capture, validate, enrich, and route claims in real time. From the first description of a loss, the system verifies coverage, assesses injury and legal severity, and cross-references reported circumstances, images, and policy data to surface inconsistencies without manual data entry.

Lazard Hires Citi Veteran Gambhir as Medical Technology Chief

Image
Lazard Hires Citi Veteran Gambhir as Medical Technology Chief

New York – September 28, 2026 -- Lazard, Inc. (NYSE: LAZ) has appointed Pranjal Gambhir as Head of Medical Technology, based in New York, as the advisory firm expands its healthcare coverage.

Gambhir brings two decades of Citi experience to Lazard's healthcare practice

Gambhir joins from Citi, where he most recently served as Managing Director covering Medical Technology companies across multiple sub-sectors. He spent 20 years at Citi in roles based in New York and New Delhi, building coverage across the sector's various segments.

Bybit, Franklin Templeton Launch Tokenized Collateral Program

Image
Bybit, Franklin Templeton Launch Tokenized Collateral Program

Dubai – September 28, 2026 -- Bybit and Franklin Templeton, a $1.7 trillion asset manager, have launched a collateral program letting institutional clients pledge tokenized money market fund shares to access trading credit on Bybit's exchange.

Institutional clients can now pledge Benji-issued fund shares for USDT or USDC credit lines

Eligible investors use ByCustody, Bybit's institutional custody platform, to pledge shares issued through Franklin Templeton's Benji Technology Platform, a blockchain-integrated recordkeeping and transfer agency infrastructure. The pledged value is mirrored inside Bybit's trading environment while the underlying assets stay off-exchange in custody, allowing clients to continue earning yield on holdings while using them to support trading activity.

Trading Technologies Names Jeanniard du Dot EVP to Lead TT Margin Unit

Image
Trading Technologies Names Jeanniard du Dot EVP to Lead TT Margin Unit

Chicago – September 28, 2026 -- Trading Technologies International, Inc. (TT) has promoted Maxime Jeanniard du Dot to Executive Vice President, Margin Analytics, putting him in charge of the TT Margin business formed after TT's acquisition of OpenGamma in December.

TT consolidates margin analytics under new executive after OpenGamma deal

Jeanniard du Dot spent 10 years as Chief Operating Officer of OpenGamma before the acquisition, giving him direct oversight of the platform now positioned as TT's core margin-analytics offering for hedge funds, asset managers, commodity trading firms and banks.